Home
Issues
Special Issues
For Authors
Topics
Conference Correspondent
- ASCO 2020 - Lung Cancer
Web Exclusives
About

Want to Receive News & Updates from AHDB?

Stay up to date on the latest information you need to devise benefit designs, make coverage decisions, and further value-based healthcare! Sign up for our newsletter or print publications today by entering your contact information below and clicking "Subscribe".

First Name *

Last Name *

Email Address *

Email Address (Verify) *

AHDB Print Edition

We will request your mailing address on the next page.

AHDB E-Newsletters & Communications

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.

Home
Issues
Special Issues
For Authors
Topics
Conference Correspondent
- ASCO 2020 - Lung Cancer
Web Exclusives
About

Al B. Benson III, MD, FACP, FASCO

Authored Items

Comparing the Cost of Treatment with Octreotide Long-Acting Release versus Lanreotide in Patients with Metastatic Gastrointestinal Neuroendocrine Tumors

Rajeev Ayyagari, PhD, Maureen Neary, PhD, MS, Shang Li, MS, Ariel Rokito, BS, Hongbo Yang, PhD, Jipan Xie, MD, PhD, Al B. Benson III, MD, FACP, FASCO

November 2017 Vol 10, No 8 in Business, Original Research

Role of NCCN in Integrating Cancer Clinical Practice Guidelines into the Healthcare Debate

Al B. Benson III, MD, FACP, FASCO, Elizabeth Brown, MD

February 2008, Vol 1, No 1 in Business

Last modified: April 23, 2019

HOME
ABOUT
CONTACT US
TERMS OF USE
PRIVACY POLICY
ADVERTISING POLICY

Copyright © Engage Healthcare Communications, LLC. All rights reserved.